Amdocs (NASDAQ:DOX)‘s stock had its “hold” rating reissued by analysts at JPMorgan Chase & Co. in a research report issued on Thursday.

Other equities analysts also recently issued research reports about the company. BidaskClub upgraded Amdocs from a “strong sell” rating to a “sell” rating in a research report on Friday, September 14th. Zacks Investment Research upgraded Amdocs from a “sell” rating to a “hold” rating in a research report on Friday, September 14th. Finally, TheStreet downgraded Amdocs from a “b” rating to a “c+” rating in a research report on Friday, November 9th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. Amdocs presently has a consensus rating of “Hold” and an average target price of $72.28.

DOX traded up $0.24 during trading on Thursday, hitting $60.00. The company’s stock had a trading volume of 601,443 shares, compared to its average volume of 669,268. Amdocs has a twelve month low of $55.89 and a twelve month high of $71.72. The firm has a market cap of $8.27 billion, a P/E ratio of 16.04, a PEG ratio of 1.78 and a beta of 0.60.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Thursday, November 8th. The technology company reported $0.90 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.02). Amdocs had a net margin of 8.92% and a return on equity of 15.06%. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $1 billion. During the same period in the previous year, the business posted $0.94 earnings per share. The firm’s revenue for the quarter was up 2.3% on a year-over-year basis. On average, analysts anticipate that Amdocs will post 3.92 earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in the stock. Penserra Capital Management LLC lifted its position in Amdocs by 16.5% during the third quarter. Penserra Capital Management LLC now owns 6,256 shares of the technology company’s stock worth $412,000 after buying an additional 884 shares in the last quarter. State of Alaska Department of Revenue lifted its position in Amdocs by 2.5% during the third quarter. State of Alaska Department of Revenue now owns 43,396 shares of the technology company’s stock worth $2,863,000 after buying an additional 1,064 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its position in Amdocs by 12.5% during the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 9,662 shares of the technology company’s stock worth $640,000 after buying an additional 1,073 shares in the last quarter. Strs Ohio lifted its position in Amdocs by 14.7% during the third quarter. Strs Ohio now owns 9,283 shares of the technology company’s stock worth $612,000 after buying an additional 1,191 shares in the last quarter. Finally, Wedge Capital Management L L P NC lifted its position in Amdocs by 11.4% during the third quarter. Wedge Capital Management L L P NC now owns 12,983 shares of the technology company’s stock worth $857,000 after buying an additional 1,333 shares in the last quarter. Hedge funds and other institutional investors own 93.61% of the company’s stock.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

See Also: Differences Between Momentum Investing and Long Term Investing

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.